Enfusion Inc Cl A (ENFN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 52,938 | 51,166 | 49,455 | 48,052 | 46,486 |
| Cost of Goods | 16,398 | 16,340 | 15,962 | 16,174 | 15,624 |
| Gross Profit | 36,540 | 34,826 | 33,493 | 31,878 | 30,862 |
| Operating Expenses | 35,354 | 32,185 | 31,752 | 33,165 | 29,352 |
| Operating Income | 1,584 | 2,981 | 2,703 | -1,113 | 2,134 |
| Other Income | 874 | -120 | 245 | 235 | 46 |
| Pre-tax Income | 2,458 | 2,861 | 2,948 | -878 | 2,180 |
| Income Tax | 2,286 | 904 | 401 | -117 | 1,280 |
| Net Income Continuous | 172 | 1,957 | 2,547 | -761 | 900 |
| Minority Interests | 51 | 542 | 721 | -222 | 277 |
| Net Income | $121 | $1,415 | $1,826 | $-539 | $623 |
| EPS Basic Total Ops | N/A | 0.02 | 0.02 | -0.01 | N/A |
| EPS Basic Continuous Ops | 0.00 | 0.02 | 0.03 | -0.01 | 0.01 |
| EPS Diluted Total Ops | N/A | 0.02 | 0.02 | -0.01 | N/A |
| EPS Diluted Continuous Ops | 0.00 | 0.02 | 0.02 | -0.01 | 0.01 |
| EPS Diluted Before Non-Recurring Items | 0.01 | 0.03 | 0.02 | -0.01 | 0.01 |
| EBITDA(a) | $4,889 | $6,000 | $5,634 | $1,620 | $5,724 |